IBEX (IBEX) AI Stock Analysis

• Market Cap: $507.58M
• Dividend Yield: N/A
• Average Volume (3M): 91.39K
• Price to Earnings (P/E): 13.6
• Beta (1Y): 0.94
• Revenue Growth: 12.86%
• EPS Growth: 54.95%
• Country: US
• Employees: 33,000
• Sector: Technology
• Sector Strength: 88
• Industry: Information Technology Services
• EPS (TTM): 0.90
• Shares Outstanding: 13,467,175
• 10 Day Avg. Volume: 80,599
• 30 Day Avg. Volume: 91,394
• PEG Ratio: 0.36
• Price to Book (P/B): 3.18
• Price to Sales (P/S): 0.77
• P/FCF Ratio: 15.65
• Enterprise Value/Market Cap: 1.25
• Enterprise Value/Revenue: 1.10
• Enterprise Value/Gross Profit: 3.58
• Enterprise Value/Ebitda: 9.23
• 1Y Price Target: $40.00
• Price Target Upside: 8.11% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 77 Outperform
• Price Target: $42.00 ▲(13.51% Upside)

IBEX's strong financial performance and positive earnings call sentiment are the primary drivers of its overall score. The company's robust revenue growth, profitability, and strategic advancements in AI and client diversification are significant strengths. Technical analysis presents mixed signals, and while the valuation is reasonable, the absence of a dividend yield is a minor drawback.

Positive Factors

Revenue Growth

Strong revenue growth in key sectors like retail and HealthTech indicates robust demand for IBEX's solutions, supporting long-term expansion.

Client Diversification

Improved client diversification reduces dependency on any single client, enhancing revenue stability and mitigating risk.

AI and Technology Advancements

Advancements in AI and leadership in technology strengthen IBEX's competitive edge and drive future innovation.

Negative Factors

Decline in Telecommunications Revenue

A significant decline in telecommunications revenue highlights vulnerability in this sector, potentially impacting overall growth.

Gross Margin Pressure

Pressure on gross margins from investments may affect short-term profitability, requiring careful cost management to sustain margins.

Equity Financing Needs

The need for improved equity financing could limit financial flexibility, affecting the ability to fund future growth initiatives.

IBEX Business Overview & Revenue Model

Company Description

IBEX is a global technology company specializing in providing digital solutions and services across various sectors, including telecommunications, healthcare, and financial services. The company focuses on developing innovative software applications, cloud-based solutions, and data analytics tools designed to enhance operational efficiency and customer engagement. IBEX's core offerings include customer experience management platforms, artificial intelligence-driven insights, and seamless integration services that cater to both enterprises and small businesses worldwide.

How the Company Makes Money

IBEX generates revenue primarily through subscription-based models for its software and digital solutions, allowing clients to access its platforms and services on a recurring basis. Additionally, the company earns income from consulting and implementation services, where it helps businesses integrate its technologies into their existing operations. Key revenue streams include licensing fees for proprietary software, transaction fees for data analytics services, and performance-based incentives linked to customer satisfaction improvements. IBEX also partners with major technology firms and industry leaders to expand its market reach and capabilities, further driving its earnings through collaborative projects and joint ventures.

IBEX Financial Statement Overview

Summary

IBEX exhibits strong financial performance with robust revenue growth, profitability, and cash flow management. The balance sheet is stable, though there is room for improvement in equity financing. Overall, the financial health is solid, positioning IBEX favorably in its industry.

Income Statement

IBEX demonstrates strong revenue growth with a TTM increase of 3.84% and consistent profitability, evidenced by a healthy gross profit margin of 30.91% and a net profit margin of 6.60%. The EBIT and EBITDA margins are robust at 8.52% and 11.60%, respectively, indicating efficient operations. The company has shown resilience in maintaining growth and profitability in a competitive industry.

Balance Sheet

IBEX maintains a solid balance sheet with a manageable debt-to-equity ratio of 0.52, reflecting prudent financial leverage. The return on equity is impressive at 27.38%, showcasing effective use of shareholder funds. However, the equity ratio of 50.58% suggests room for improvement in asset financing through equity.

Cash Flow

The company exhibits strong cash flow management with a free cash flow growth rate of 14.29% and a healthy free cash flow to net income ratio of 59.76%. The operating cash flow to net income ratio stands at 57.13%, indicating good cash conversion efficiency. These metrics highlight IBEX's ability to generate and manage cash effectively.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	579.74M	558.27M	508.57M	523.12M	492.85M	443.39M
Gross Profit	177.51M	172.58M	152.03M	148.13M	118.88M	108.14M
EBITDA	68.86M	64.80M	60.96M	60.10M	38.77M	31.16M
Net Income	41.38M	36.86M	33.66M	31.58M	21.46M	13.09M
Balance Sheet
Total Assets	283.86M	273.21M	293.90M	293.32M	294.18M	274.29M
Cash, Cash Equivalents and Short-Term Investments	22.69M	15.35M	62.72M	57.43M	48.83M	57.84M
Total Debt	66.54M	69.75M	67.02M	78.90M	105.54M	112.52M
Total Liabilities	140.23M	138.91M	128.10M	143.36M	180.72M	193.63M
Stockholders Equity	143.63M	134.31M	165.80M	149.96M	113.46M	80.66M
Cash Flow
Free Cash Flow	31.19M	27.29M	27.05M	22.91M	14.09M	-4.75M
Operating Cash Flow	53.58M	45.67M	35.90M	41.86M	40.01M	16.08M
Investing Cash Flow	-22.38M	-18.38M	-8.86M	-19.04M	-25.92M	-20.82M
Financing Cash Flow	-70.71M	-74.66M	-21.73M	-13.61M	-22.13M	40.90M

IBEX Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 37.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IBEX, the sentiment is Positive. The current price of 37 is above the 20-day moving average (MA) of 35.65, above the 50-day MA of 36.54, and above the 200-day MA of 30.74, indicating a bullish trend. The MACD of 0.15 indicates Negative momentum. The RSI at 61.93 is Neutral, neither overbought nor oversold. The STOCH value of 81.38 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IBEX.

IBEX Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IBEX	77 Outperform	$507.58M	13.57	26.29%	―	12.86%	54.95%
INOD	67 Neutral	$1.67B	54.02	46.40%	―	73.57%	56.21%
HCKT	65 Neutral	$542.07M	51.78	10.27%	2.35%	0.68%	-67.84%
TASK	62 Neutral	$1.10B	13.97	15.40%	―	19.88%	51.03%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
TSSI	46 Neutral	$218.65M	38.56	13.73%	―	91.66%	7.52%
UIS	45 Neutral	$208.93M	-0.63	―	―	-4.93%	18.65%

IBEX Corporate Events

Ibex Forms Nominating Committee for Board Oversight

On November 20, 2025, Ibex Limited’s Board of Directors established a formal Nominating Committee to oversee the nomination of board members, a task previously handled by independent board members. This move aligns with Nasdaq Global Market rules and aims to address concerns raised by Institutional Shareholder Services Inc. and Glass Lewis & Co., LLC regarding the nominating process. The Committee’s responsibilities include identifying and recommending qualified director candidates and ensuring compliance with Nasdaq’s independence requirements. The Committee ratified past actions and recommended a slate of director candidates for the upcoming annual meeting on December 5, 2025, urging shareholders to vote in favor of the nominees.